Connection

David Potter to Dopamine Agonists

This is a "connection" page, showing publications David Potter has written about Dopamine Agonists.
Connection Strength

0.673
  1. Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent. J Ocul Pharmacol Ther. 2002 Dec; 18(6):507-14.
    View in: PubMed
    Score: 0.198
  2. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist. J Pharmacol Exp Ther. 2000 Jun; 293(3):710-6.
    View in: PubMed
    Score: 0.166
  3. Potential sites of action of TNPA: a dopamine-2 receptor agonist. Exp Eye Res. 1999 Dec; 69(6):611-6.
    View in: PubMed
    Score: 0.160
  4. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis. Pharmacology. 1998 Nov; 57(5):249-60.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.